Aptus Capital Advisors’s JPMorgan International Research Enhanced Equity ETF JIRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$99.2K Buy
1,203
+290
+32% +$23.3K ﹤0.01% 1257
2026
Q1
$69.2K Buy
913
+135
+17% +$10.5K ﹤0.01% 1225
2025
Q4
$58.3K Buy
778
+212
+37% +$15.8K ﹤0.01% 1272
2025
Q3
$41.6K Buy
566
+460
+434% +$33K ﹤0.01% 1258
2025
Q2
$7.5K Buy
106
+20
+23% +$1.33K ﹤0.01% 1389
2025
Q1
$5.48K Sell
86
-75
-47% -$4.7K ﹤0.01% 1328
2024
Q4
$9.42K Buy
161
+26
+19% +$1.62K ﹤0.01% 1285
2024
Q3
$8.91K Buy
+135
New +$8.65K ﹤0.01% 1104
2023
Q1
Sell
-303
Closed -$15.2K 844
2022
Q4
$15.2K Sell
303
-37
-11% -$1.8K ﹤0.01% 671
2022
Q3
$15K Buy
+340
New +$16.5K ﹤0.01% 632

Other funds holding JIRE

Aptus Capital Advisors's JIRE Position: Q2 2026 in Review

Aptus Capital Advisors increased its JPMorgan International Research Enhanced Equity ETF (JIRE) stake by 32% in Q2 2026, buying an estimated $23.3K and bringing the position to 1,203 shares worth $99.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1257.

Aptus Capital Advisors first reported a position in JIRE in Q3 2022 and has held it in 10 quarters since. 350 funds tracked by Wall St. Rank hold JIRE as of Q2 2026.

  • Aptus Capital Advisors held 1,203 shares of JPMorgan International Research Enhanced Equity ETF worth $99.2K as of Q2 2026.
  • Aptus Capital Advisors bought 290 JPMorgan International Research Enhanced Equity ETF shares in Q2 2026, an estimated $23.3K.
  • JPMorgan International Research Enhanced Equity ETF made up ﹤0.01% of Aptus Capital Advisors's portfolio in Q2 2026, its #1257 holding.
  • Aptus Capital Advisors first reported a position in JPMorgan International Research Enhanced Equity ETF in Q3 2022 and has held it in 10 quarters since.
  • 350 funds tracked by Wall St. Rank held JPMorgan International Research Enhanced Equity ETF as of Q2 2026.

Based on Aptus Capital Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.